By David Morgan | Jan 17, 2013 09:23 AM EST
At least 22 governors support an expansion of Medicaid under President Barack Obama's healthcare reform law, while others are expected to decide in the coming weeks.
By David Morgan | Jan 10, 2013 07:57 AM EST
The US could save $2 trillion in healthcare spending over the next decade, if the government used its influence in the public and private sectors to nudge soaring costs into line with economic growth.
By David Morgan | Jan 08, 2013 10:14 AM EST
U.S. healthcare spending rose at a historically low rate of 3.9 percent for the third consecutive year in 2011, but showed underlying signs of acceleration as the economy recovered from recession.
By David Morgan | Jan 06, 2013 01:15 PM EST
President Barack Obama could seek common ground with Republicans in the looming battle over Medicare spending.
By David Morgan | Dec 20, 2012 08:20 AM EST
The top U.S. drug regulator urged state officials to help close regulatory loopholes involving the safety of compounded drugs, such as the tainted steroid injections at the center of a deadly fungal meningitis outbreak.
By David Morgan | Dec 14, 2012 09:53 AM EST
Fourteen U.S. states and the District of Columbia so far have told the federal government they plan to operate healthcare exchanges under President Barack Obama's reform law.
By David Morgan | Dec 08, 2012 03:25 PM EST
A USFDA panel of outside experts voted against recommending Zogenix Inc's Zohydro painkiller for FDA approval on Friday.
By David Morgan | Nov 21, 2012 09:17 AM EST
The U.S. administration proposed new health insurance rules aimed at ending discrimination against the sick and guaranteeing minimum benefits for millions of Americans.
By David Morgan | Nov 19, 2012 04:56 PM EST
Republicans on a congressional panel investigating a deadly meningitis outbreak told FDA not to expect new authority to prevent future problems until the agency hands over documents about its role in the current crisis.
By David Morgan | Nov 17, 2012 02:51 PM EST
Five Republican governors rejected on Friday a major provision of President Barack Obama's healthcare reform law.
By David Morgan | Nov 16, 2012 10:00 AM EST
Lawmakers said they would alter the regulation of drug compounding pharmacies to prevent more crises like the recent meningitis outbreak.
By David Morgan | Nov 14, 2012 09:50 AM EST
US and state health regulators called on Congress to strengthen federal oversight of compounding pharmacies as lawmakers prepared for two days of hearings on a deadly fungal meningitis outbreak linked to a compounded steroid.
By David Morgan | Oct 29, 2012 11:28 AM EDT
FDA's power to regulate compounded drugs similar to those linked to a deadly meningitis outbreak is legally nonbinding and lacks the authority of stringent standards imposed on drug manufacturers.
By David Morgan | Oct 23, 2012 09:05 AM EDT
U.S. and Massachusetts state health regulators were aware in 2002 that steroid treatments from the pharmacy at the center of a deadly meningitis outbreak could cause adverse patient reactions.
By David Morgan | Oct 12, 2012 10:07 AM EDT
The pharmacy at the center of a deadly meningitis outbreak was asked to brief lawmakers about the role that its products may have played in the crisis.
